170,000 Patients Supported with Impella® Heart Pumps
With today’s innovative technology, minimally invasive treatment options allow patients to recover the function of their native heart.
Patients and Caregivers
Protected PCI can be a safe treatment option to address severe coronary artery disease or advanced heart failure.
Health Care Professionals
Explore clinical data, educational opportunities and resources regarding the latest breakthroughs in cardiac and respiratory research.
Abiomed Second Quarter Fiscal 2022 Earnings and Conference Call Notification
October 7, 2021
FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump
August 18, 2021